Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Francesco Lo‐Coco(Fondazione Santa Lucia), Alan K. Burnett(Cardiff University), Pierre Fenaux(Saint Louis University Hospital), Bob Löwenberg(Unknown), Elihu H. Estey(University of Washington), Thomas Büchner(The University of Texas MD Anderson Cancer Center), Hartmut Döhner(University Hospital Ulm), David Grimwade(King's College School), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Tomoki Naoe(National Hospital Organization), Eva Lengfelder
Blood
September 24, 2008
10.1182/blood-2008-04-150250
Cited by 957

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
|Blood|2009|3.4k
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k